DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $169,000 | +8.3% | 1,185 | 0.0% | 0.11% | +11.2% |
| Q1 2019 | $156,000 | -6.0% | 1,185 | -26.2% | 0.10% | -17.6% |
| Q4 2018 | $166,000 | -7.8% | 1,605 | -3.0% | 0.12% | +25.3% |
| Q3 2018 | $180,000 | -13.9% | 1,655 | -21.7% | 0.10% | -18.8% |
| Q2 2018 | $209,000 | +1.0% | 2,115 | 0.0% | 0.12% | -8.6% |
| Q1 2018 | $207,000 | +6.2% | 2,115 | +0.7% | 0.13% | +10.3% |
| Q4 2017 | $195,000 | +8.9% | 2,100 | +0.7% | 0.12% | +9.4% |
| Q3 2017 | $179,000 | -1.6% | 2,085 | -3.6% | 0.11% | -10.9% |
| Q2 2017 | $182,000 | -7.1% | 2,162 | -5.4% | 0.12% | -0.8% |
| Q1 2017 | $196,000 | +16.0% | 2,286 | +5.3% | 0.12% | +4.3% |
| Q4 2016 | $169,000 | -0.6% | 2,171 | 0.0% | 0.12% | -1.7% |
| Q3 2016 | $170,000 | -19.0% | 2,171 | +4.4% | 0.12% | -12.7% |
| Q2 2016 | $210,000 | +60.3% | 2,079 | +51.1% | 0.13% | +48.9% |
| Q1 2016 | $131,000 | – | 1,376 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |